Former Ro director launches Allara, a care platform for PCOS – TechCrunch
But Blank left her director position at the health tech unicorn, last valued at $5 billion, to start her own company in women’s hormonal health. Hormonal health grows biggerAllara is the latest startup to bet that hormonal health is a key wedge into the digital health boom. “There’s been a lack of understanding what women’s health means,” Blank said, explaining how society often views it as a fertility or reproductive health condition. Notably, Ro did acquire Modern Fertility, a hormonal health company, for north of $225 million, last month. “Allara is not a primary care platform — it’s a specialty care platform, developing new clinical care models for complex women’s health conditions like PCOS.